nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—CYP2C8—Levothyroxine—hypothyroidism	0.113	0.42	CbGbCtD
Bortezomib—CYP2C8—Liotrix—hypothyroidism	0.11	0.41	CbGbCtD
Bortezomib—CYP3A4—Levothyroxine—hypothyroidism	0.0457	0.17	CbGbCtD
Bortezomib—Cardio-respiratory arrest—Liothyronine—hypothyroidism	0.015	0.0457	CcSEcCtD
Bortezomib—Infertility—Levothyroxine—hypothyroidism	0.0101	0.0307	CcSEcCtD
Bortezomib—Infertility—Dextrothyroxine—hypothyroidism	0.0101	0.0307	CcSEcCtD
Bortezomib—Bronchopneumonia—Liotrix—hypothyroidism	0.00887	0.027	CcSEcCtD
Bortezomib—Infertility—Liotrix—hypothyroidism	0.00742	0.0226	CcSEcCtD
Bortezomib—Faecaloma—Liotrix—hypothyroidism	0.00678	0.0207	CcSEcCtD
Bortezomib—Faecalith—Liotrix—hypothyroidism	0.00678	0.0207	CcSEcCtD
Bortezomib—Hyperthyroidism—Levothyroxine—hypothyroidism	0.00666	0.0203	CcSEcCtD
Bortezomib—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.00666	0.0203	CcSEcCtD
Bortezomib—Hyperphosphataemia—Liotrix—hypothyroidism	0.00567	0.0173	CcSEcCtD
Bortezomib—Muscle twitching—Liothyronine—hypothyroidism	0.00546	0.0166	CcSEcCtD
Bortezomib—Cardio-respiratory arrest—Liotrix—hypothyroidism	0.00542	0.0165	CcSEcCtD
Bortezomib—CTSG—heart—hypothyroidism	0.00526	0.0187	CbGeAlD
Bortezomib—PSMA1—heart—hypothyroidism	0.00505	0.018	CbGeAlD
Bortezomib—CTSG—cardiovascular system—hypothyroidism	0.00496	0.0177	CbGeAlD
Bortezomib—Hyperthyroidism—Liotrix—hypothyroidism	0.0049	0.0149	CcSEcCtD
Bortezomib—PSMA1—cardiovascular system—hypothyroidism	0.00476	0.017	CbGeAlD
Bortezomib—Phlebitis—Liothyronine—hypothyroidism	0.00452	0.0138	CcSEcCtD
Bortezomib—PSMD1—adrenal cortex—hypothyroidism	0.00438	0.0156	CbGeAlD
Bortezomib—PSMA1—gonad—hypothyroidism	0.00432	0.0154	CbGeAlD
Bortezomib—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00429	0.0131	CcSEcCtD
Bortezomib—PSMD1—heart—hypothyroidism	0.00424	0.0151	CbGeAlD
Bortezomib—CYP2C19—urine—hypothyroidism	0.004	0.0143	CbGeAlD
Bortezomib—Throat tightness—Liotrix—hypothyroidism	0.00395	0.012	CcSEcCtD
Bortezomib—CTSG—adrenal gland—hypothyroidism	0.00392	0.014	CbGeAlD
Bortezomib—CTSG—blood—hypothyroidism	0.00392	0.014	CbGeAlD
Bortezomib—PSMD2—adrenal cortex—hypothyroidism	0.00388	0.0138	CbGeAlD
Bortezomib—PSMB8—adrenal cortex—hypothyroidism	0.00386	0.0137	CbGeAlD
Bortezomib—PSMA1—adrenal gland—hypothyroidism	0.00377	0.0134	CbGeAlD
Bortezomib—PSMD2—heart—hypothyroidism	0.00375	0.0134	CbGeAlD
Bortezomib—PSMB8—heart—hypothyroidism	0.00373	0.0133	CbGeAlD
Bortezomib—Hypernatraemia—Liotrix—hypothyroidism	0.00368	0.0112	CcSEcCtD
Bortezomib—PSMA1—thyroid gland—hypothyroidism	0.00363	0.013	CbGeAlD
Bortezomib—PSMD2—cardiovascular system—hypothyroidism	0.00354	0.0126	CbGeAlD
Bortezomib—PSMD1—pituitary gland—hypothyroidism	0.00354	0.0126	CbGeAlD
Bortezomib—PSMA1—female gonad—hypothyroidism	0.00351	0.0125	CbGeAlD
Bortezomib—Acidosis—Liotrix—hypothyroidism	0.0035	0.0107	CcSEcCtD
Bortezomib—PSMB5—adrenal cortex—hypothyroidism	0.00341	0.0121	CbGeAlD
Bortezomib—PSMB5—heart—hypothyroidism	0.00329	0.0117	CbGeAlD
Bortezomib—Angina pectoris—Liothyronine—hypothyroidism	0.00328	0.00998	CcSEcCtD
Bortezomib—CYP1A2—urine—hypothyroidism	0.00327	0.0117	CbGeAlD
Bortezomib—CTSG—testis—hypothyroidism	0.00324	0.0116	CbGeAlD
Bortezomib—PSMD2—gonad—hypothyroidism	0.00321	0.0115	CbGeAlD
Bortezomib—PSMD1—adrenal gland—hypothyroidism	0.00316	0.0113	CbGeAlD
Bortezomib—PSMD1—blood—hypothyroidism	0.00316	0.0113	CbGeAlD
Bortezomib—PSMD2—pituitary gland—hypothyroidism	0.00314	0.0112	CbGeAlD
Bortezomib—PSMB8—pituitary gland—hypothyroidism	0.00312	0.0111	CbGeAlD
Bortezomib—PSMA1—testis—hypothyroidism	0.00311	0.0111	CbGeAlD
Bortezomib—Fluid overload—Liotrix—hypothyroidism	0.00311	0.00949	CcSEcCtD
Bortezomib—CYP2C9—urine—hypothyroidism	0.0031	0.0111	CbGeAlD
Bortezomib—PSMD1—thyroid gland—hypothyroidism	0.00305	0.0109	CbGeAlD
Bortezomib—PSMB1—adrenal cortex—hypothyroidism	0.00298	0.0106	CbGeAlD
Bortezomib—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00296	0.00901	CcSEcCtD
Bortezomib—PSMD1—female gonad—hypothyroidism	0.00295	0.0105	CbGeAlD
Bortezomib—PSMA1—liver—hypothyroidism	0.00294	0.0105	CbGeAlD
Bortezomib—Myocardial infarction—Liothyronine—hypothyroidism	0.00294	0.00896	CcSEcCtD
Bortezomib—PSMB2—adrenal cortex—hypothyroidism	0.00291	0.0104	CbGeAlD
Bortezomib—PSMB1—heart—hypothyroidism	0.00288	0.0103	CbGeAlD
Bortezomib—PSMA1—cerebellum—hypothyroidism	0.00288	0.0103	CbGeAlD
Bortezomib—Intestinal obstruction—Liotrix—hypothyroidism	0.00284	0.00866	CcSEcCtD
Bortezomib—PSMB2—heart—hypothyroidism	0.00281	0.01	CbGeAlD
Bortezomib—PSMD2—adrenal gland—hypothyroidism	0.0028	0.00999	CbGeAlD
Bortezomib—PSMD2—blood—hypothyroidism	0.0028	0.00998	CbGeAlD
Bortezomib—PSMB8—adrenal gland—hypothyroidism	0.00278	0.00992	CbGeAlD
Bortezomib—PSMB8—blood—hypothyroidism	0.00278	0.00992	CbGeAlD
Bortezomib—PSMB5—pituitary gland—hypothyroidism	0.00275	0.00981	CbGeAlD
Bortezomib—PSMB1—cardiovascular system—hypothyroidism	0.00272	0.00969	CbGeAlD
Bortezomib—PSMD2—thyroid gland—hypothyroidism	0.0027	0.00964	CbGeAlD
Bortezomib—PSMB8—thyroid gland—hypothyroidism	0.00269	0.00958	CbGeAlD
Bortezomib—PSMB2—cardiovascular system—hypothyroidism	0.00265	0.00945	CbGeAlD
Bortezomib—PSMD1—testis—hypothyroidism	0.00261	0.00932	CbGeAlD
Bortezomib—PSMD2—female gonad—hypothyroidism	0.00261	0.00931	CbGeAlD
Bortezomib—PSMB8—female gonad—hypothyroidism	0.0026	0.00925	CbGeAlD
Bortezomib—Wheezing—Dextrothyroxine—hypothyroidism	0.00256	0.00779	CcSEcCtD
Bortezomib—Wheezing—Levothyroxine—hypothyroidism	0.00256	0.00779	CcSEcCtD
Bortezomib—SLC31A1—adrenal cortex—hypothyroidism	0.00252	0.00897	CbGeAlD
Bortezomib—Coagulopathy—Liotrix—hypothyroidism	0.00249	0.00758	CcSEcCtD
Bortezomib—PSMD1—liver—hypothyroidism	0.00247	0.00881	CbGeAlD
Bortezomib—PSMB1—gonad—hypothyroidism	0.00247	0.00879	CbGeAlD
Bortezomib—PSMB5—adrenal gland—hypothyroidism	0.00246	0.00877	CbGeAlD
Bortezomib—PSMB5—blood—hypothyroidism	0.00246	0.00876	CbGeAlD
Bortezomib—SLC31A1—heart—hypothyroidism	0.00243	0.00867	CbGeAlD
Bortezomib—PSMD1—cerebellum—hypothyroidism	0.00241	0.00861	CbGeAlD
Bortezomib—PSMB2—gonad—hypothyroidism	0.00241	0.00858	CbGeAlD
Bortezomib—PSMB1—pituitary gland—hypothyroidism	0.00241	0.00858	CbGeAlD
Bortezomib—Coma—Dextrothyroxine—hypothyroidism	0.00241	0.00733	CcSEcCtD
Bortezomib—Coma—Levothyroxine—hypothyroidism	0.00241	0.00733	CcSEcCtD
Bortezomib—Arrhythmia—Liothyronine—hypothyroidism	0.0024	0.00733	CcSEcCtD
Bortezomib—PSMB5—thyroid gland—hypothyroidism	0.00237	0.00846	CbGeAlD
Bortezomib—CYP3A4—urine—hypothyroidism	0.00237	0.00844	CbGeAlD
Bortezomib—PSMB2—pituitary gland—hypothyroidism	0.00235	0.00837	CbGeAlD
Bortezomib—CYP2D6—urine—hypothyroidism	0.00233	0.0083	CbGeAlD
Bortezomib—PSMD2—testis—hypothyroidism	0.00232	0.00826	CbGeAlD
Bortezomib—PSMB8—testis—hypothyroidism	0.0023	0.00821	CbGeAlD
Bortezomib—PSMB5—female gonad—hypothyroidism	0.00229	0.00817	CbGeAlD
Bortezomib—Extravasation—Liotrix—hypothyroidism	0.00222	0.00676	CcSEcCtD
Bortezomib—Tenderness—Liotrix—hypothyroidism	0.00222	0.00676	CcSEcCtD
Bortezomib—PSMD2—liver—hypothyroidism	0.00219	0.00781	CbGeAlD
Bortezomib—PSMB8—liver—hypothyroidism	0.00218	0.00776	CbGeAlD
Bortezomib—PSMB1—adrenal gland—hypothyroidism	0.00215	0.00766	CbGeAlD
Bortezomib—PSMB1—blood—hypothyroidism	0.00215	0.00766	CbGeAlD
Bortezomib—PSMD2—cerebellum—hypothyroidism	0.00214	0.00763	CbGeAlD
Bortezomib—Cellulitis—Liotrix—hypothyroidism	0.00213	0.00649	CcSEcCtD
Bortezomib—Hypocalcaemia—Liotrix—hypothyroidism	0.00212	0.00645	CcSEcCtD
Bortezomib—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00211	0.00642	CcSEcCtD
Bortezomib—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00211	0.00642	CcSEcCtD
Bortezomib—Oliguria—Liotrix—hypothyroidism	0.0021	0.0064	CcSEcCtD
Bortezomib—PSMB2—adrenal gland—hypothyroidism	0.0021	0.00748	CbGeAlD
Bortezomib—PSMB2—blood—hypothyroidism	0.0021	0.00747	CbGeAlD
Bortezomib—SLC31A1—gonad—hypothyroidism	0.00208	0.00743	CbGeAlD
Bortezomib—PSMB1—thyroid gland—hypothyroidism	0.00207	0.00739	CbGeAlD
Bortezomib—Ulcer—Liotrix—hypothyroidism	0.00205	0.00624	CcSEcCtD
Bortezomib—Increased appetite—Levothyroxine—hypothyroidism	0.00203	0.0062	CcSEcCtD
Bortezomib—Increased appetite—Dextrothyroxine—hypothyroidism	0.00203	0.0062	CcSEcCtD
Bortezomib—PSMB5—testis—hypothyroidism	0.00203	0.00725	CbGeAlD
Bortezomib—SLC31A1—pituitary gland—hypothyroidism	0.00203	0.00725	CbGeAlD
Bortezomib—PSMB2—thyroid gland—hypothyroidism	0.00202	0.00721	CbGeAlD
Bortezomib—Hypertension—Liothyronine—hypothyroidism	0.00202	0.00617	CcSEcCtD
Bortezomib—PSMB1—female gonad—hypothyroidism	0.002	0.00714	CbGeAlD
Bortezomib—Muscle twitching—Liotrix—hypothyroidism	0.00197	0.00601	CcSEcCtD
Bortezomib—Cardiac failure—Levothyroxine—hypothyroidism	0.00196	0.00597	CcSEcCtD
Bortezomib—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00196	0.00597	CcSEcCtD
Bortezomib—PSMB2—female gonad—hypothyroidism	0.00196	0.00697	CbGeAlD
Bortezomib—PSMB5—liver—hypothyroidism	0.00192	0.00685	CbGeAlD
Bortezomib—Wheezing—Liotrix—hypothyroidism	0.00188	0.00573	CcSEcCtD
Bortezomib—PSMB5—cerebellum—hypothyroidism	0.00188	0.0067	CbGeAlD
Bortezomib—Tachycardia—Liothyronine—hypothyroidism	0.00187	0.00569	CcSEcCtD
Bortezomib—Fluid retention—Liotrix—hypothyroidism	0.00184	0.0056	CcSEcCtD
Bortezomib—Irritability—Levothyroxine—hypothyroidism	0.00182	0.00556	CcSEcCtD
Bortezomib—Irritability—Dextrothyroxine—hypothyroidism	0.00182	0.00556	CcSEcCtD
Bortezomib—Cardiac arrest—Levothyroxine—hypothyroidism	0.00182	0.00554	CcSEcCtD
Bortezomib—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00182	0.00554	CcSEcCtD
Bortezomib—SLC31A1—adrenal gland—hypothyroidism	0.00182	0.00647	CbGeAlD
Bortezomib—SLC31A1—blood—hypothyroidism	0.00182	0.00647	CbGeAlD
Bortezomib—Hypotension—Liothyronine—hypothyroidism	0.00179	0.00545	CcSEcCtD
Bortezomib—PSMB1—testis—hypothyroidism	0.00178	0.00634	CbGeAlD
Bortezomib—Dehydration—Dextrothyroxine—hypothyroidism	0.00178	0.00542	CcSEcCtD
Bortezomib—Dehydration—Levothyroxine—hypothyroidism	0.00178	0.00542	CcSEcCtD
Bortezomib—Coma—Liotrix—hypothyroidism	0.00177	0.00539	CcSEcCtD
Bortezomib—SLC31A1—thyroid gland—hypothyroidism	0.00175	0.00625	CbGeAlD
Bortezomib—PSMB2—testis—hypothyroidism	0.00173	0.00618	CbGeAlD
Bortezomib—SLC31A1—female gonad—hypothyroidism	0.00169	0.00604	CbGeAlD
Bortezomib—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00169	0.00514	CcSEcCtD
Bortezomib—Muscular weakness—Levothyroxine—hypothyroidism	0.00169	0.00514	CcSEcCtD
Bortezomib—PSMB1—liver—hypothyroidism	0.00168	0.00599	CbGeAlD
Bortezomib—Sepsis—Liotrix—hypothyroidism	0.00168	0.00512	CcSEcCtD
Bortezomib—Dysphagia—Dextrothyroxine—hypothyroidism	0.00165	0.00503	CcSEcCtD
Bortezomib—Dysphagia—Levothyroxine—hypothyroidism	0.00165	0.00503	CcSEcCtD
Bortezomib—PSMB1—cerebellum—hypothyroidism	0.00164	0.00585	CbGeAlD
Bortezomib—PSMB2—liver—hypothyroidism	0.00164	0.00585	CbGeAlD
Bortezomib—Phlebitis—Liotrix—hypothyroidism	0.00163	0.00497	CcSEcCtD
Bortezomib—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00161	0.0049	CcSEcCtD
Bortezomib—Angina pectoris—Levothyroxine—hypothyroidism	0.00161	0.0049	CcSEcCtD
Bortezomib—PSMB2—cerebellum—hypothyroidism	0.0016	0.00571	CbGeAlD
Bortezomib—Cardiac failure congestive—Liotrix—hypothyroidism	0.00155	0.00472	CcSEcCtD
Bortezomib—Renal failure acute—Liotrix—hypothyroidism	0.00152	0.00464	CcSEcCtD
Bortezomib—Body temperature increased—Liothyronine—hypothyroidism	0.00151	0.00461	CcSEcCtD
Bortezomib—SLC31A1—testis—hypothyroidism	0.0015	0.00535	CbGeAlD
Bortezomib—Increased appetite—Liotrix—hypothyroidism	0.0015	0.00456	CcSEcCtD
Bortezomib—Weight decreased—Dextrothyroxine—hypothyroidism	0.00149	0.00455	CcSEcCtD
Bortezomib—Weight decreased—Levothyroxine—hypothyroidism	0.00149	0.00455	CcSEcCtD
Bortezomib—Renal impairment—Liotrix—hypothyroidism	0.00148	0.0045	CcSEcCtD
Bortezomib—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00145	0.00442	CcSEcCtD
Bortezomib—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00145	0.00442	CcSEcCtD
Bortezomib—Myocardial infarction—Levothyroxine—hypothyroidism	0.00144	0.0044	CcSEcCtD
Bortezomib—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00144	0.0044	CcSEcCtD
Bortezomib—Cardiac failure—Liotrix—hypothyroidism	0.00144	0.00439	CcSEcCtD
Bortezomib—SLC31A1—liver—hypothyroidism	0.00142	0.00506	CbGeAlD
Bortezomib—SLC31A1—cerebellum—hypothyroidism	0.00139	0.00495	CbGeAlD
Bortezomib—Irritability—Liotrix—hypothyroidism	0.00134	0.00409	CcSEcCtD
Bortezomib—Cardiac arrest—Liotrix—hypothyroidism	0.00134	0.00407	CcSEcCtD
Bortezomib—Dehydration—Liotrix—hypothyroidism	0.00131	0.00398	CcSEcCtD
Bortezomib—Hypokalaemia—Liotrix—hypothyroidism	0.00128	0.0039	CcSEcCtD
Bortezomib—Muscular weakness—Liotrix—hypothyroidism	0.00124	0.00378	CcSEcCtD
Bortezomib—Flushing—Levothyroxine—hypothyroidism	0.00123	0.00374	CcSEcCtD
Bortezomib—Flushing—Dextrothyroxine—hypothyroidism	0.00123	0.00374	CcSEcCtD
Bortezomib—Abdominal distension—Liotrix—hypothyroidism	0.00122	0.00373	CcSEcCtD
Bortezomib—Dysphagia—Liotrix—hypothyroidism	0.00121	0.0037	CcSEcCtD
Bortezomib—Bronchospasm—Liotrix—hypothyroidism	0.00119	0.00364	CcSEcCtD
Bortezomib—Angina pectoris—Liotrix—hypothyroidism	0.00118	0.00361	CcSEcCtD
Bortezomib—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00118	0.0036	CcSEcCtD
Bortezomib—Arrhythmia—Levothyroxine—hypothyroidism	0.00118	0.0036	CcSEcCtD
Bortezomib—Bronchitis—Liotrix—hypothyroidism	0.00117	0.00356	CcSEcCtD
Bortezomib—Weight decreased—Liotrix—hypothyroidism	0.0011	0.00335	CcSEcCtD
Bortezomib—Tremor—Levothyroxine—hypothyroidism	0.00108	0.00329	CcSEcCtD
Bortezomib—Tremor—Dextrothyroxine—hypothyroidism	0.00108	0.00329	CcSEcCtD
Bortezomib—Acute coronary syndrome—Liotrix—hypothyroidism	0.00107	0.00325	CcSEcCtD
Bortezomib—Renal failure—Liotrix—hypothyroidism	0.00106	0.00325	CcSEcCtD
Bortezomib—Myocardial infarction—Liotrix—hypothyroidism	0.00106	0.00324	CcSEcCtD
Bortezomib—Agitation—Dextrothyroxine—hypothyroidism	0.00106	0.00322	CcSEcCtD
Bortezomib—Agitation—Levothyroxine—hypothyroidism	0.00106	0.00322	CcSEcCtD
Bortezomib—Angioedema—Levothyroxine—hypothyroidism	0.00105	0.0032	CcSEcCtD
Bortezomib—Angioedema—Dextrothyroxine—hypothyroidism	0.00105	0.0032	CcSEcCtD
Bortezomib—Palpitations—Levothyroxine—hypothyroidism	0.00102	0.0031	CcSEcCtD
Bortezomib—Palpitations—Dextrothyroxine—hypothyroidism	0.00102	0.0031	CcSEcCtD
Bortezomib—Convulsion—Dextrothyroxine—hypothyroidism	0.000997	0.00304	CcSEcCtD
Bortezomib—Convulsion—Levothyroxine—hypothyroidism	0.000997	0.00304	CcSEcCtD
Bortezomib—Arthralgia—Dextrothyroxine—hypothyroidism	0.00098	0.00299	CcSEcCtD
Bortezomib—Arthralgia—Levothyroxine—hypothyroidism	0.00098	0.00299	CcSEcCtD
Bortezomib—Anxiety—Dextrothyroxine—hypothyroidism	0.000976	0.00298	CcSEcCtD
Bortezomib—Anxiety—Levothyroxine—hypothyroidism	0.000976	0.00298	CcSEcCtD
Bortezomib—Hypoaesthesia—Liotrix—hypothyroidism	0.000968	0.00295	CcSEcCtD
Bortezomib—Confusional state—Dextrothyroxine—hypothyroidism	0.000947	0.00289	CcSEcCtD
Bortezomib—Confusional state—Levothyroxine—hypothyroidism	0.000947	0.00289	CcSEcCtD
Bortezomib—Shock—Levothyroxine—hypothyroidism	0.000924	0.00282	CcSEcCtD
Bortezomib—Shock—Dextrothyroxine—hypothyroidism	0.000924	0.00282	CcSEcCtD
Bortezomib—Tachycardia—Dextrothyroxine—hypothyroidism	0.000917	0.00279	CcSEcCtD
Bortezomib—Tachycardia—Levothyroxine—hypothyroidism	0.000917	0.00279	CcSEcCtD
Bortezomib—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000908	0.00277	CcSEcCtD
Bortezomib—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000908	0.00277	CcSEcCtD
Bortezomib—Flushing—Liotrix—hypothyroidism	0.000902	0.00275	CcSEcCtD
Bortezomib—Arrhythmia—Liotrix—hypothyroidism	0.000869	0.00265	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000856	0.00261	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000856	0.00261	CcSEcCtD
Bortezomib—Insomnia—Dextrothyroxine—hypothyroidism	0.000849	0.00259	CcSEcCtD
Bortezomib—Insomnia—Levothyroxine—hypothyroidism	0.000849	0.00259	CcSEcCtD
Bortezomib—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000837	0.00255	CcSEcCtD
Bortezomib—Dyspnoea—Levothyroxine—hypothyroidism	0.000837	0.00255	CcSEcCtD
Bortezomib—Flatulence—Liotrix—hypothyroidism	0.000834	0.00254	CcSEcCtD
Bortezomib—Dysgeusia—Liotrix—hypothyroidism	0.000829	0.00253	CcSEcCtD
Bortezomib—CYP1A1—heart—hypothyroidism	0.000826	0.00295	CbGeAlD
Bortezomib—Fatigue—Levothyroxine—hypothyroidism	0.00081	0.00247	CcSEcCtD
Bortezomib—Fatigue—Dextrothyroxine—hypothyroidism	0.00081	0.00247	CcSEcCtD
Bortezomib—Vision blurred—Liotrix—hypothyroidism	0.000798	0.00243	CcSEcCtD
Bortezomib—CYP2C9—heart—hypothyroidism	0.000795	0.00284	CbGeAlD
Bortezomib—Tremor—Liotrix—hypothyroidism	0.000793	0.00242	CcSEcCtD
Bortezomib—Agitation—Liotrix—hypothyroidism	0.000778	0.00237	CcSEcCtD
Bortezomib—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000774	0.00236	CcSEcCtD
Bortezomib—Feeling abnormal—Levothyroxine—hypothyroidism	0.000774	0.00236	CcSEcCtD
Bortezomib—Angioedema—Liotrix—hypothyroidism	0.000773	0.00236	CcSEcCtD
Bortezomib—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000768	0.00234	CcSEcCtD
Bortezomib—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000768	0.00234	CcSEcCtD
Bortezomib—CYP2C19—blood—hypothyroidism	0.000765	0.00273	CbGeAlD
Bortezomib—Syncope—Liotrix—hypothyroidism	0.000759	0.00231	CcSEcCtD
Bortezomib—CYP2C9—cardiovascular system—hypothyroidism	0.00075	0.00268	CbGeAlD
Bortezomib—Palpitations—Liotrix—hypothyroidism	0.000748	0.00228	CcSEcCtD
Bortezomib—CYP2C8—pituitary gland—hypothyroidism	0.000748	0.00267	CbGeAlD
Bortezomib—Urticaria—Dextrothyroxine—hypothyroidism	0.000746	0.00227	CcSEcCtD
Bortezomib—Urticaria—Levothyroxine—hypothyroidism	0.000746	0.00227	CcSEcCtD
Bortezomib—Loss of consciousness—Liotrix—hypothyroidism	0.000744	0.00227	CcSEcCtD
Bortezomib—Abdominal pain—Levothyroxine—hypothyroidism	0.000742	0.00226	CcSEcCtD
Bortezomib—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000742	0.00226	CcSEcCtD
Bortezomib—Body temperature increased—Levothyroxine—hypothyroidism	0.000742	0.00226	CcSEcCtD
Bortezomib—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000742	0.00226	CcSEcCtD
Bortezomib—Convulsion—Liotrix—hypothyroidism	0.000733	0.00224	CcSEcCtD
Bortezomib—Hypertension—Liotrix—hypothyroidism	0.000731	0.00223	CcSEcCtD
Bortezomib—PTGS1—heart—hypothyroidism	0.000726	0.00259	CbGeAlD
Bortezomib—Arthralgia—Liotrix—hypothyroidism	0.000721	0.0022	CcSEcCtD
Bortezomib—Chest pain—Liotrix—hypothyroidism	0.000721	0.0022	CcSEcCtD
Bortezomib—Anxiety—Liotrix—hypothyroidism	0.000718	0.00219	CcSEcCtD
Bortezomib—Confusional state—Liotrix—hypothyroidism	0.000697	0.00212	CcSEcCtD
Bortezomib—Anaphylactic shock—Liotrix—hypothyroidism	0.000691	0.00211	CcSEcCtD
Bortezomib—Oedema—Liotrix—hypothyroidism	0.000691	0.00211	CcSEcCtD
Bortezomib—Infection—Liotrix—hypothyroidism	0.000686	0.00209	CcSEcCtD
Bortezomib—PTGS1—cardiovascular system—hypothyroidism	0.000685	0.00244	CbGeAlD
Bortezomib—Shock—Liotrix—hypothyroidism	0.00068	0.00207	CcSEcCtD
Bortezomib—Tachycardia—Liotrix—hypothyroidism	0.000674	0.00205	CcSEcCtD
Bortezomib—Asthenia—Levothyroxine—hypothyroidism	0.000674	0.00205	CcSEcCtD
Bortezomib—Asthenia—Dextrothyroxine—hypothyroidism	0.000674	0.00205	CcSEcCtD
Bortezomib—CYP2C8—blood—hypothyroidism	0.000668	0.00238	CbGeAlD
Bortezomib—Hyperhidrosis—Liotrix—hypothyroidism	0.000668	0.00204	CcSEcCtD
Bortezomib—Pruritus—Levothyroxine—hypothyroidism	0.000664	0.00203	CcSEcCtD
Bortezomib—Pruritus—Dextrothyroxine—hypothyroidism	0.000664	0.00203	CcSEcCtD
Bortezomib—Anorexia—Liotrix—hypothyroidism	0.000659	0.00201	CcSEcCtD
Bortezomib—Hypotension—Liotrix—hypothyroidism	0.000646	0.00197	CcSEcCtD
Bortezomib—Diarrhoea—Levothyroxine—hypothyroidism	0.000643	0.00196	CcSEcCtD
Bortezomib—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000643	0.00196	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000629	0.00192	CcSEcCtD
Bortezomib—CYP1A2—blood—hypothyroidism	0.000625	0.00223	CbGeAlD
Bortezomib—Insomnia—Liotrix—hypothyroidism	0.000625	0.0019	CcSEcCtD
Bortezomib—Paraesthesia—Liotrix—hypothyroidism	0.00062	0.00189	CcSEcCtD
Bortezomib—CYP1A1—blood—hypothyroidism	0.000617	0.0022	CbGeAlD
Bortezomib—Dyspnoea—Liotrix—hypothyroidism	0.000616	0.00188	CcSEcCtD
Bortezomib—PTGS1—pituitary gland—hypothyroidism	0.000607	0.00216	CbGeAlD
Bortezomib—CYP1A2—thyroid gland—hypothyroidism	0.000603	0.00215	CbGeAlD
Bortezomib—Decreased appetite—Liotrix—hypothyroidism	0.000601	0.00183	CcSEcCtD
Bortezomib—CYP2C19—liver—hypothyroidism	0.000599	0.00213	CbGeAlD
Bortezomib—Vomiting—Dextrothyroxine—hypothyroidism	0.000597	0.00182	CcSEcCtD
Bortezomib—Vomiting—Levothyroxine—hypothyroidism	0.000597	0.00182	CcSEcCtD
Bortezomib—Fatigue—Liotrix—hypothyroidism	0.000596	0.00182	CcSEcCtD
Bortezomib—CYP1A1—thyroid gland—hypothyroidism	0.000595	0.00212	CbGeAlD
Bortezomib—CYP2C9—blood—hypothyroidism	0.000593	0.00212	CbGeAlD
Bortezomib—Rash—Dextrothyroxine—hypothyroidism	0.000592	0.0018	CcSEcCtD
Bortezomib—Rash—Levothyroxine—hypothyroidism	0.000592	0.0018	CcSEcCtD
Bortezomib—Dermatitis—Dextrothyroxine—hypothyroidism	0.000592	0.0018	CcSEcCtD
Bortezomib—Dermatitis—Levothyroxine—hypothyroidism	0.000592	0.0018	CcSEcCtD
Bortezomib—Constipation—Liotrix—hypothyroidism	0.000591	0.0018	CcSEcCtD
Bortezomib—Headache—Dextrothyroxine—hypothyroidism	0.000588	0.00179	CcSEcCtD
Bortezomib—Headache—Levothyroxine—hypothyroidism	0.000588	0.00179	CcSEcCtD
Bortezomib—CYP1A1—female gonad—hypothyroidism	0.000575	0.00205	CbGeAlD
Bortezomib—Feeling abnormal—Liotrix—hypothyroidism	0.000569	0.00174	CcSEcCtD
Bortezomib—Gastrointestinal pain—Liotrix—hypothyroidism	0.000565	0.00172	CcSEcCtD
Bortezomib—Nausea—Levothyroxine—hypothyroidism	0.000558	0.0017	CcSEcCtD
Bortezomib—Nausea—Dextrothyroxine—hypothyroidism	0.000558	0.0017	CcSEcCtD
Bortezomib—CYP2C8—testis—hypothyroidism	0.000553	0.00197	CbGeAlD
Bortezomib—Urticaria—Liotrix—hypothyroidism	0.000549	0.00167	CcSEcCtD
Bortezomib—Body temperature increased—Liotrix—hypothyroidism	0.000546	0.00166	CcSEcCtD
Bortezomib—Abdominal pain—Liotrix—hypothyroidism	0.000546	0.00166	CcSEcCtD
Bortezomib—PTGS1—adrenal gland—hypothyroidism	0.000542	0.00193	CbGeAlD
Bortezomib—PTGS1—blood—hypothyroidism	0.000542	0.00193	CbGeAlD
Bortezomib—PTGS1—thyroid gland—hypothyroidism	0.000523	0.00186	CbGeAlD
Bortezomib—CYP2C8—liver—hypothyroidism	0.000522	0.00186	CbGeAlD
Bortezomib—Hypersensitivity—Liotrix—hypothyroidism	0.000509	0.00155	CcSEcCtD
Bortezomib—PTGS1—female gonad—hypothyroidism	0.000505	0.0018	CbGeAlD
Bortezomib—Asthenia—Liotrix—hypothyroidism	0.000496	0.00151	CcSEcCtD
Bortezomib—CYP1A2—liver—hypothyroidism	0.000489	0.00174	CbGeAlD
Bortezomib—Pruritus—Liotrix—hypothyroidism	0.000489	0.00149	CcSEcCtD
Bortezomib—CYP1A1—liver—hypothyroidism	0.000482	0.00172	CbGeAlD
Bortezomib—Diarrhoea—Liotrix—hypothyroidism	0.000473	0.00144	CcSEcCtD
Bortezomib—CYP2C9—liver—hypothyroidism	0.000464	0.00165	CbGeAlD
Bortezomib—Dizziness—Liotrix—hypothyroidism	0.000457	0.00139	CcSEcCtD
Bortezomib—CYP3A4—blood—hypothyroidism	0.000453	0.00161	CbGeAlD
Bortezomib—PTGS1—testis—hypothyroidism	0.000448	0.0016	CbGeAlD
Bortezomib—CYP2D6—blood—hypothyroidism	0.000445	0.00159	CbGeAlD
Bortezomib—Vomiting—Liotrix—hypothyroidism	0.000439	0.00134	CcSEcCtD
Bortezomib—Rash—Liotrix—hypothyroidism	0.000436	0.00133	CcSEcCtD
Bortezomib—Dermatitis—Liotrix—hypothyroidism	0.000435	0.00133	CcSEcCtD
Bortezomib—Headache—Liotrix—hypothyroidism	0.000433	0.00132	CcSEcCtD
Bortezomib—CYP2D6—female gonad—hypothyroidism	0.000415	0.00148	CbGeAlD
Bortezomib—Nausea—Liotrix—hypothyroidism	0.00041	0.00125	CcSEcCtD
Bortezomib—CYP2D6—testis—hypothyroidism	0.000368	0.00131	CbGeAlD
Bortezomib—CYP3A4—liver—hypothyroidism	0.000354	0.00126	CbGeAlD
Bortezomib—CYP2D6—liver—hypothyroidism	0.000348	0.00124	CbGeAlD
Bortezomib—CYP2D6—cerebellum—hypothyroidism	0.00034	0.00121	CbGeAlD
Bortezomib—PSMA1—Gene Expression—NKX2-5—hypothyroidism	0.000323	0.00262	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—CLTC—hypothyroidism	0.000322	0.00261	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CLTC—hypothyroidism	0.000322	0.00261	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CLTC—hypothyroidism	0.000322	0.00261	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—NKX2-5—hypothyroidism	0.000321	0.00261	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—NKX2-5—hypothyroidism	0.00032	0.0026	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—CLTC—hypothyroidism	0.000317	0.00258	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—IYD—hypothyroidism	0.000314	0.00255	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—IYD—hypothyroidism	0.000314	0.00255	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—IYD—hypothyroidism	0.000314	0.00255	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—IYD—hypothyroidism	0.000309	0.00251	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.0003	0.00244	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—THRB—hypothyroidism	0.000292	0.00237	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—THRB—hypothyroidism	0.00029	0.00236	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—THRB—hypothyroidism	0.000289	0.00235	CbGpPWpGaD
Bortezomib—CTSG—Metabolism of proteins—POMC—hypothyroidism	0.000283	0.0023	CbGpPWpGaD
Bortezomib—CTSG—Metabolism of proteins—IGF1—hypothyroidism	0.000273	0.00221	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—ATP5O—hypothyroidism	0.000267	0.00217	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—ATP5O—hypothyroidism	0.000267	0.00217	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—ATP5O—hypothyroidism	0.000267	0.00217	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—ATP5O—hypothyroidism	0.000263	0.00214	CbGpPWpGaD
Bortezomib—PTGS1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000262	0.00213	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CLTC—hypothyroidism	0.000257	0.00209	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CLTC—hypothyroidism	0.000256	0.00208	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CLTC—hypothyroidism	0.000255	0.00207	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—TPO—hypothyroidism	0.000251	0.00204	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—TPO—hypothyroidism	0.000251	0.00204	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—TPO—hypothyroidism	0.000251	0.00204	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—TPO—hypothyroidism	0.000247	0.00201	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—NKX2-5—hypothyroidism	0.000245	0.00199	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—NKX2-5—hypothyroidism	0.000245	0.00199	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—NKX2-5—hypothyroidism	0.000245	0.00199	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—NKX2-5—hypothyroidism	0.000241	0.00196	CbGpPWpGaD
Bortezomib—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000228	0.00185	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—THRB—hypothyroidism	0.000221	0.0018	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—THRB—hypothyroidism	0.000221	0.0018	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—THRB—hypothyroidism	0.000221	0.0018	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—THRB—hypothyroidism	0.000218	0.00177	CbGpPWpGaD
Bortezomib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000209	0.00169	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CLTC—hypothyroidism	0.000195	0.00158	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CLTC—hypothyroidism	0.000195	0.00158	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CLTC—hypothyroidism	0.000195	0.00158	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CLTC—hypothyroidism	0.000192	0.00156	CbGpPWpGaD
Bortezomib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000186	0.00151	CbGpPWpGaD
Bortezomib—CYP1A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000185	0.0015	CbGpPWpGaD
Bortezomib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000171	0.00139	CbGpPWpGaD
Bortezomib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00017	0.00138	CbGpPWpGaD
Bortezomib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000169	0.00137	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CLTC—hypothyroidism	0.000166	0.00135	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CLTC—hypothyroidism	0.000166	0.00135	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CLTC—hypothyroidism	0.000165	0.00134	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—IYD—hypothyroidism	0.000164	0.00133	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—TSHB—hypothyroidism	0.000153	0.00125	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—TSHB—hypothyroidism	0.000153	0.00124	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—TSHB—hypothyroidism	0.000152	0.00123	CbGpPWpGaD
Bortezomib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000151	0.00123	CbGpPWpGaD
Bortezomib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000145	0.00118	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TRH—hypothyroidism	0.000144	0.00117	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TRH—hypothyroidism	0.000143	0.00116	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TRH—hypothyroidism	0.000142	0.00116	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ATP5O—hypothyroidism	0.00014	0.00113	CbGpPWpGaD
Bortezomib—PTGS1—Biological oxidations—POMC—hypothyroidism	0.000139	0.00113	CbGpPWpGaD
Bortezomib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000139	0.00113	CbGpPWpGaD
Bortezomib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000138	0.00112	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—PIK3C2A—hypothyroidism	0.000137	0.00111	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—PIK3C2A—hypothyroidism	0.000136	0.0011	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—PIK3C2A—hypothyroidism	0.000135	0.0011	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—TPO—hypothyroidism	0.000131	0.00107	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—PRL—hypothyroidism	0.000131	0.00106	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—PRL—hypothyroidism	0.00013	0.00106	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—PRL—hypothyroidism	0.00013	0.00105	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TSHB—hypothyroidism	0.000128	0.00104	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TSHR—hypothyroidism	0.000128	0.00104	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TSHB—hypothyroidism	0.000128	0.00104	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TSHR—hypothyroidism	0.000128	0.00104	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TSHB—hypothyroidism	0.000127	0.00103	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TSHR—hypothyroidism	0.000127	0.00103	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CLTC—hypothyroidism	0.000126	0.00102	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CLTC—hypothyroidism	0.000126	0.00102	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CLTC—hypothyroidism	0.000126	0.00102	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CLTC—hypothyroidism	0.000124	0.00101	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000122	0.000987	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—VAV3—hypothyroidism	0.000121	0.000985	CbGpPWpGaD
Bortezomib—PSMA1—Disease—PRL—hypothyroidism	0.000121	0.000983	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—VAV3—hypothyroidism	0.000121	0.00098	CbGpPWpGaD
Bortezomib—PSMD1—Disease—PRL—hypothyroidism	0.00012	0.000979	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—VAV3—hypothyroidism	0.00012	0.000976	CbGpPWpGaD
Bortezomib—PSMD2—Disease—PRL—hypothyroidism	0.00012	0.000974	CbGpPWpGaD
Bortezomib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000118	0.000956	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—TSHB—hypothyroidism	0.000116	0.000944	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—TSHB—hypothyroidism	0.000116	0.000944	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—TSHB—hypothyroidism	0.000116	0.000944	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—IYD—hypothyroidism	0.000116	0.000939	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—SLC5A5—hypothyroidism	0.000115	0.000932	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—TSHB—hypothyroidism	0.000115	0.00093	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—SH2B3—hypothyroidism	0.000114	0.000928	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—SLC5A5—hypothyroidism	0.000114	0.000928	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—SH2B3—hypothyroidism	0.000114	0.000924	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—SLC5A5—hypothyroidism	0.000114	0.000923	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—SH2B3—hypothyroidism	0.000113	0.000919	CbGpPWpGaD
Bortezomib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000112	0.00091	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TRH—hypothyroidism	0.000109	0.000885	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TRH—hypothyroidism	0.000109	0.000885	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TRH—hypothyroidism	0.000109	0.000885	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TRH—hypothyroidism	0.000107	0.000873	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—IYD—hypothyroidism	0.000106	0.000861	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PIK3C2A—hypothyroidism	0.000104	0.000841	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PIK3C2A—hypothyroidism	0.000104	0.000841	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PIK3C2A—hypothyroidism	0.000104	0.000841	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PIK3C2A—hypothyroidism	0.000102	0.000829	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—PRL—hypothyroidism	9.94e-05	0.000807	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—PRL—hypothyroidism	9.94e-05	0.000807	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—PRL—hypothyroidism	9.94e-05	0.000807	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ATP5O—hypothyroidism	9.83e-05	0.000799	CbGpPWpGaD
Bortezomib—CYP1A1—Biological oxidations—POMC—hypothyroidism	9.8e-05	0.000796	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—PRL—hypothyroidism	9.8e-05	0.000796	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TSHB—hypothyroidism	9.72e-05	0.000789	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TSHB—hypothyroidism	9.72e-05	0.000789	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TSHB—hypothyroidism	9.72e-05	0.000789	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TSHR—hypothyroidism	9.72e-05	0.000789	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TSHR—hypothyroidism	9.72e-05	0.000789	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TSHR—hypothyroidism	9.72e-05	0.000789	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TSHB—hypothyroidism	9.58e-05	0.000778	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TSHR—hypothyroidism	9.58e-05	0.000778	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—IYD—hypothyroidism	9.46e-05	0.000769	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—TPO—hypothyroidism	9.24e-05	0.000751	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—VAV3—hypothyroidism	9.19e-05	0.000747	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—VAV3—hypothyroidism	9.19e-05	0.000747	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—VAV3—hypothyroidism	9.19e-05	0.000747	CbGpPWpGaD
Bortezomib—PSMB1—Disease—PRL—hypothyroidism	9.17e-05	0.000745	CbGpPWpGaD
Bortezomib—PSMB5—Disease—PRL—hypothyroidism	9.17e-05	0.000745	CbGpPWpGaD
Bortezomib—PSMB2—Disease—PRL—hypothyroidism	9.17e-05	0.000745	CbGpPWpGaD
Bortezomib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	9.08e-05	0.000737	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—VAV3—hypothyroidism	9.06e-05	0.000736	CbGpPWpGaD
Bortezomib—PSMB8—Disease—PRL—hypothyroidism	9.04e-05	0.000735	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ATP5O—hypothyroidism	9.01e-05	0.000732	CbGpPWpGaD
Bortezomib—CYP2C8—Biological oxidations—POMC—hypothyroidism	8.99e-05	0.00073	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—IYD—hypothyroidism	8.7e-05	0.000707	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—SLC5A5—hypothyroidism	8.7e-05	0.000706	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—SLC5A5—hypothyroidism	8.7e-05	0.000706	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—SLC5A5—hypothyroidism	8.7e-05	0.000706	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—SH2B3—hypothyroidism	8.66e-05	0.000703	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—SH2B3—hypothyroidism	8.66e-05	0.000703	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—SH2B3—hypothyroidism	8.66e-05	0.000703	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—IYD—hypothyroidism	8.63e-05	0.000701	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—SLC5A5—hypothyroidism	8.57e-05	0.000696	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.56e-05	0.000696	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—SH2B3—hypothyroidism	8.54e-05	0.000693	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—PRL—hypothyroidism	8.48e-05	0.000689	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—TPO—hypothyroidism	8.47e-05	0.000688	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—PRL—hypothyroidism	8.44e-05	0.000685	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—PRL—hypothyroidism	8.4e-05	0.000682	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ATP5O—hypothyroidism	8.05e-05	0.000654	CbGpPWpGaD
Bortezomib—CYP2C19—Biological oxidations—POMC—hypothyroidism	8.02e-05	0.000651	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.85e-05	0.000638	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—VAV3—hypothyroidism	7.84e-05	0.000637	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—VAV3—hypothyroidism	7.8e-05	0.000634	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—VAV3—hypothyroidism	7.77e-05	0.000631	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—TPO—hypothyroidism	7.56e-05	0.000614	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—AVP—hypothyroidism	7.56e-05	0.000614	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—AVP—hypothyroidism	7.52e-05	0.000611	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—AVP—hypothyroidism	7.48e-05	0.000608	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ATP5O—hypothyroidism	7.4e-05	0.000601	CbGpPWpGaD
Bortezomib—CYP2D6—Biological oxidations—POMC—hypothyroidism	7.38e-05	0.000599	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—IYD—hypothyroidism	7.37e-05	0.000599	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ATP5O—hypothyroidism	7.34e-05	0.000596	CbGpPWpGaD
Bortezomib—CYP2C9—Biological oxidations—POMC—hypothyroidism	7.31e-05	0.000594	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.01e-05	0.000569	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—TPO—hypothyroidism	6.96e-05	0.000565	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—TPO—hypothyroidism	6.9e-05	0.00056	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—PRL—hypothyroidism	6.42e-05	0.000522	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—PRL—hypothyroidism	6.42e-05	0.000522	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—PRL—hypothyroidism	6.42e-05	0.000522	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.39e-05	0.000519	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—PRL—hypothyroidism	6.33e-05	0.000514	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ATP5O—hypothyroidism	6.27e-05	0.000509	CbGpPWpGaD
Bortezomib—CYP1A2—Biological oxidations—POMC—hypothyroidism	6.25e-05	0.000508	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—TSHB—hypothyroidism	6.07e-05	0.000493	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—POMC—hypothyroidism	6e-05	0.000488	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—POMC—hypothyroidism	5.98e-05	0.000485	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—POMC—hypothyroidism	5.95e-05	0.000483	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—VAV3—hypothyroidism	5.94e-05	0.000483	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—VAV3—hypothyroidism	5.94e-05	0.000483	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—VAV3—hypothyroidism	5.94e-05	0.000483	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—TPO—hypothyroidism	5.89e-05	0.000479	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—VAV3—hypothyroidism	5.86e-05	0.000476	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—AVP—hypothyroidism	5.73e-05	0.000465	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—AVP—hypothyroidism	5.73e-05	0.000465	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—AVP—hypothyroidism	5.73e-05	0.000465	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—IYD—hypothyroidism	5.69e-05	0.000462	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—AVP—hypothyroidism	5.65e-05	0.000459	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.46e-05	0.000444	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PIK3C2A—hypothyroidism	5.41e-05	0.00044	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.34e-05	0.000434	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—POMC—hypothyroidism	5.02e-05	0.000408	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—POMC—hypothyroidism	5e-05	0.000406	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—POMC—hypothyroidism	4.97e-05	0.000404	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ATP5O—hypothyroidism	4.84e-05	0.000393	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—IGF1—hypothyroidism	4.83e-05	0.000392	CbGpPWpGaD
Bortezomib—CYP3A4—Biological oxidations—POMC—hypothyroidism	4.82e-05	0.000392	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—IGF1—hypothyroidism	4.81e-05	0.00039	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—IGF1—hypothyroidism	4.78e-05	0.000389	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—POMC—hypothyroidism	4.55e-05	0.00037	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—POMC—hypothyroidism	4.55e-05	0.00037	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—POMC—hypothyroidism	4.55e-05	0.00037	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—TPO—hypothyroidism	4.55e-05	0.000369	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—SLC5A5—hypothyroidism	4.55e-05	0.000369	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—POMC—hypothyroidism	4.49e-05	0.000364	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—TSHB—hypothyroidism	4.28e-05	0.000348	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—TSHB—hypothyroidism	3.92e-05	0.000319	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PIK3C2A—hypothyroidism	3.81e-05	0.00031	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—POMC—hypothyroidism	3.81e-05	0.000309	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—POMC—hypothyroidism	3.81e-05	0.000309	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—POMC—hypothyroidism	3.81e-05	0.000309	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.76e-05	0.000306	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—POMC—hypothyroidism	3.75e-05	0.000305	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IGF1—hypothyroidism	3.66e-05	0.000297	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IGF1—hypothyroidism	3.66e-05	0.000297	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IGF1—hypothyroidism	3.66e-05	0.000297	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IGF1—hypothyroidism	3.61e-05	0.000293	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—TSHB—hypothyroidism	3.5e-05	0.000284	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	3.5e-05	0.000284	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.45e-05	0.00028	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—TSHB—hypothyroidism	3.22e-05	0.000262	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—SLC5A5—hypothyroidism	3.2e-05	0.00026	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—TSHB—hypothyroidism	3.19e-05	0.000259	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	3.12e-05	0.000254	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.08e-05	0.00025	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—SLC5A5—hypothyroidism	2.94e-05	0.000239	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	2.87e-05	0.000233	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	2.85e-05	0.000231	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.81e-05	0.000228	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—TSHB—hypothyroidism	2.73e-05	0.000222	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—SLC5A5—hypothyroidism	2.62e-05	0.000213	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	2.43e-05	0.000198	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—SLC5A5—hypothyroidism	2.41e-05	0.000196	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.4e-05	0.000195	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—SLC5A5—hypothyroidism	2.39e-05	0.000194	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—POMC—hypothyroidism	2.38e-05	0.000193	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—TSHB—hypothyroidism	2.11e-05	0.000171	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SLC5A5—hypothyroidism	2.04e-05	0.000166	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.88e-05	0.000152	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—POMC—hypothyroidism	1.68e-05	0.000136	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.58e-05	0.000128	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—POMC—hypothyroidism	1.54e-05	0.000125	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—POMC—hypothyroidism	1.37e-05	0.000111	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—POMC—hypothyroidism	1.26e-05	0.000102	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—POMC—hypothyroidism	1.25e-05	0.000102	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—POMC—hypothyroidism	1.07e-05	8.68e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—POMC—hypothyroidism	8.25e-06	6.7e-05	CbGpPWpGaD
